Skip to main content
QURE
NASDAQ Life Sciences

uniQure's AMT-260 Gene Therapy Shows 79-100% Seizure Reduction in Some Epilepsy Patients

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$46.5
Mkt Cap
$2.894B
52W Low
$8.73
52W High
$71.5
52W Position info
433% above low
Off High info
35% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

QURE has more than doubled off its 52-week low of $8.73 on elevated volume (2.3× avg).

Summary

uniQure announced preliminary Phase I/IIa data for its gene therapy candidate AMT-260 in refractory mesial temporal lobe epilepsy, showing positive safety and early efficacy signals. Three of six patients in the low-dose cohort achieved significant seizure reductions ranging from 79% to 100%. This early data for a new pipeline asset adds to the company's recent positive developments, including the planned BLA submission for AMT-130 in Huntington's disease. The positive safety profile and observed responses support continued evaluation of AMT-260, with updated results from a higher dose cohort expected in the first half of 2027.

At the time of this announcement, QURE was trading at $46.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $8.73 to $71.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

QURE - Latest Insights

QURE
Nov 04, 2026, 7:28 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.60
Real-time Price: $20.12 info
Change: -$2.48 (-11%) info
Market Cap: $1.357B info
QURE
Nov 04, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.44
Real-time Price: $20.12 info
Change: -$2.32 (-10%) info
Market Cap: $1.357B info
QURE
Nov 02, 2026, 7:05 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $27.66
Real-time Price: $20.12 info
Change: -$7.54 (-27%) info
Market Cap: $1.357B info
QURE
Sep 29, 2026, 9:26 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $22.00
Real-time Price: $20.12 info
Change: -$1.88 (-9%) info
Market Cap: $1.357B info
QURE
Sep 29, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.20
Real-time Price: $20.12 info
Change: -$2.08 (-9%) info
Market Cap: $1.357B info